Checking on patients at the Alcor Life Extension Foundation in Scottsdale, Arizona Jesse Rieser/New York
Ariel Zeleznikow-Johnston (Penguin, 28 November)
Much of medicine today focuses on extending life by no more than several months. Drugs for cancer and Alzheimer’s disease that are touted for their effectiveness often do little more than give people a bit more time. What if we could send terminally ill people forward to be saved by the medicine of the future, asks Ariel Zeleznikow-Johnston.
It is an interesting question, and one that Zeleznikow-Johnston, a neuroscientist, poses in his book, The Future Loves…
